Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives

Systemic immunoglobulin light chain (AL) amyloidosis is a disorder characterized by the production of clonal serum free light chains that misfold, aggregate, and deposit in vital organs. Treatment of this disease is typically targeted at the abnormal plasma cell clone in the bone marrow which is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarosiek, Shayna, Sanchorawala, Vaishali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815750/
https://www.ncbi.nlm.nih.gov/pubmed/31695543
http://dx.doi.org/10.2147/JBM.S183857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815750/
https://www.ncbi.nlm.nih.gov/pubmed/31695543
http://dx.doi.org/10.2147/JBM.S183857

Ejemplares similares